RT Journal Article
SR Electronic
T1 Prevalence of mechanical assisted cough in the Norwegian neuropediatric population
JF European Respiratory Journal
JO Eur Respir J
FD European Respiratory Society
SP 3115
DO 10.1183/13993003.congress-2020.3115
VO 56
IS suppl 64
A1 Brit Hov
A1 Tiina Andersen
A1 Michel Toussaint
A1 Maria Vollsæter
A1 Ingvild Bruun Mikalsen
A1 Solfrid Indrekvam
A1 Vegard Hovland
YR 2020
UL http://erj.ersjournals.com/content/56/suppl_64/3115.abstract
AB Background: Mechanical insufflation-exsufflation (MI-E) to augment cough is suggested in patients with neurological conditions at all ages when the cough is weak. The prevalence of long-term MI-E in pediatrics is unknown.Aim: To determine the prevalence of long-term MI-E use in the Norwegian neuropediatric population.Method: A population based cross-sectional study was performed. All Norwegian children equipped with a MI-E device for long-term use was identified by the units supplying technical treatment equipment for home use (4/2017). The Norwegian Patient Registry reported the children’s diagnosis, age and regional residency as well as aggregated data on children <18 years with a diagnosis in ICD-10 Chapter G; “Diseases in nervous system”. Treatment data was supplied by the Norwegian register for long-term mechanical ventilation, a questionnaire and data card in the MI-E devices.Results: In total 114 of 18861 children registered with a neurological condition in the Norwegian Patient Registry were equipped with a MI-E device for long-term use, giving a point prevalence of 6 per 1000 children, varying from 2.1 to 11.9 per 1000 children in the four health regions. The median (min-max) age was 10.7 (1.5-18) yrs. The highest prevalence was found in spinal muscular atrophy, with 24 of 76 children registered with a MI-E device (316/1000), followed by 36 of 535 children with muscular dystrophies/myopathies (67/1000). Among children with cerebral palsy 29 of 2938 had a MI-E device (9.2/1000).Conclution:MI-E was used from 1.5 yrs and was most common in children with spinal muscular atrophy. The overall prevalence of MI-E users in the Norwegian neuropediatric population varies among the four health regions.FootnotesCite this article as: European Respiratory Journal 2020; 56: Suppl. 64, 3115.This abstract was presented at the 2020 ERS International Congress, in session “Respiratory viruses in the "pre COVID-19" era”.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).